platelet-rich-plasma-lysate-for-treatment-of-eye-surface-diseases

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Various ocular surface diseases are treated with blood-derived eye drops. Their use has been introduced in clinical practice because of their metabolite ...

AUSL-IRCCS di Reggio Emilia

The first wave of coronavirus disease-2019 (COVID-19) dramatically affected the Transfusion Medicine Unit of the Azienda Unità Sanitari Locale - Istituto di Ricovero e Cura a Carattere Scientifico (AUSL-IRCCS) di Reggio Emilia, which faced a total rearrangement of the procedures for donors and patients. This study aims to assess the major implications of COVID-19 on our department, focusing on the blood transfusion chain and therapies, in order to support transfusion specialists in seeking efficient ways to face similar future emergencies.

Chiara Marraccini

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Transfusion Medicine Unit

AUSL-IRCCS di Reggio Emilia

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Transfusion Medicine Unit